Advanced search

152 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Marinomed Biotech AG, 2023 Earnings Call, Apr 16, 2024	Apr. 16
Marinomed Biotech AG announces results for the 2023 financial year and reports progress with Marinosolv and Carragelose assets	Apr. 16	EQ
Marinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of the 2019 venture loan for 18 months	Mar. 28	EQ
Marinomed Biotech AG announces preliminary revenue for 2023	Feb. 14	EQ
Marinomed Biotech AG evaluates strategic options for Carragelose portfolio	Dec. 18	EQ
Transcript : Marinomed Biotech AG, Nine Months 2023 Earnings Call, Nov 21, 2023	Nov. 21
Marinomed Biotech AG: Stable revenues in the first three quarters of 2023 and further progress in business development	Nov. 21	EQ
Marinomed Biotech AG resumes Nice & Green Convertible Notes Funding Program with reduced volume	23-10-17	EQ
Transcript : Marinomed Biotech AG, H1 2023 Earnings Call, Aug 17, 2023	23-08-17
Marinomed Biotech AG reports record revenues in the first half of the year and pushes business development activities	23-08-17	EQ
Transcript : Marinomed Biotech AG, Q1 2023 Earnings Call, May 23, 2023	23-05-23
Marinomed Biotech AG reports best first quarter in company history	23-05-23	EQ
Transcript : Marinomed Biotech AG, 2022 Earnings Call, Apr 19, 2023	23-04-19
Marinomed Biotech AG with Carragelose record sales in 2022 and positive outlook for 2023	23-04-19	EQ
Pyrum Innovations AG: Chairman of the Supervisory Board increases his shareholding in the company	23-02-27	EQ
Marinomed Biotech AG announces preliminary revenue for 2022 with double-digit growth for Carragelose	23-02-16	EQ
WWF and Beiersdorf extend cooperation for more sustainable palm oil production in Indonesia until 2026	23-01-25	AQ
Marinomed Biotech AG: Marinomed Biotech receives US Patent approval for the Marinosolv® technology and invests in a series of new patents	22-12-27	EQ
Marinomed Biotech : Investor Presentation Q3 2022	22-11-21	PU
Marinomed Biotech AG reports increase in revenues for the first 9 months 2022 and significant business development progress	22-11-21	EQ
Marinomed Biotech : Conference Call Invitation Results Q3 2022	22-11-11	PU
Marinomed Biotech : Investor Presentation LSX Inv€$tival November 2022	22-11-10	PU
Transcript : Innergex Renewable Energy Inc. - Analyst/Investor Day	22-09-20
Marinomed Biotech : to attend several upcoming investor and industry conferences	22-09-13	PU
Marinomed to attend several upcoming investor and industry conferences	22-09-13	EQ
Marinomed Biotech : Investor Presentation H1 2022	22-08-25	PU
Marinomed Biotech : continues its growth path and reports strong financials in H1 2022	22-08-25	PU
Marinomed Biotech AG continues its growth path and reports strong financials in H1 2022	22-08-25	EQ
Marinomed Biotech : Conference Call Invitation - Half Year Results 2022	22-08-11	PU
Marinomed Biotech : to pause issuing of tranches of Convertible Notes Funding Program to Nice & Green	22-07-21	PU
Marinomed to pause issuing of tranches of Convertible Notes Funding Program to Nice & Green	22-07-21	EQ
Marinomed Biotech : Investor Presentation Equity Forum 2022	22-06-09	PU
Transcript : Daiichi Sankyo Company, Limited - Special Call	22-06-07
Marinomed Biotech : Resolution proposals of the management and the supervisory board 2021 (convenience translation)	22-05-24	PU
Marinomed Biotech : Investor Presentation Equity Forum	22-05-23	PU
Transcript : Marinomed Biotech AG, Q1 2022 Earnings Call, May 23, 2022	22-05-23
Marinomed Biotech : Investor Presentation Q1 2022	22-05-23	PU
Marinomed Biotech AG reports strong 1st quarter 2022: continued growth trajectory for Carragelose	22-05-23	EQ
Marinomed Biotech : Update Q1 2022	22-05-19	PU
Marinomed to attend several upcoming investor conferences	22-05-17	EQ
Transcript : Roche Holding AG - Special Call	22-05-16
Transcript : Marinomed Biotech AG, 2021 Earnings Call, Apr 13, 2022	22-04-13
Marinomed Biotech : Investor Presentation - Full Year Results 2021	22-04-13	PU
Marinomed reports on strong 2021 financial year	22-04-13	EQ
Marinomed Biotech : Conference Call Invitation - Full Year Results 2021	22-03-31	PU
Supervisory Board of Pyrum Innovations AG extends contract with CEO Pascal Klein and appoints Kai Winkelmann to the Executive Board	22-03-30	EQ
Supervisory Board of Pyrum Innovations AG extends contract with CEO Pascal Klein and appoints Kai Winkelmann to the Executive Board	22-03-30	AQ
Transcript : Byggmax Group AB, 2021 Earnings Call, Jan 26, 2022	22-01-26
Beiersdorf Ramps up Climate Action on Product Level, Successful Reduction of Greenhouse Gas Emissions in Aerosol Segment	21-12-02	AQ
Marinomed to present at Munich capital market conference (MKK)	21-12-01	EQ

No results for this search

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer